The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Open accessAbstract
Cancer immunotherapies that train or stimulate the inherent immunological systems to recognize, attack, and eradicate tumor cells with minimal damage to healthy cells have demonstrated promising clinical responses in recent years. However, most of these immunotherapeutic strategies only benefit a small subset of patients and cause systemic autoimmune side effects in some patients. Immunogenic cell death (ICD)‐inducing modalities not only directly kill cancer cells but also induce antitumor immune responses against a broad spectrum of solid tumors. Such strategies for generating vaccine‐like functions could be used to stimulate a “cold” tumor microenvironment to become an immunogenic, “hot” tumor microenvironment, working in synergy with immunotherapies to increase patient response rates and lead to successful treatment outcomes. This Minireview will focus on nanoparticle‐based treatment modalities that can induce and enhance ICD to potentiate cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Research works printed but not linked: 108
- 10.1038/ni1102-991 · DOI · Paper page
- 10.1126/science.1203486 · DOI · Paper page
- 10.1016/j.nantod.2014.10.001 · DOI
- 10.1016/j.jconrel.2018.01.028 · DOI
- 10.1126/science.aaa3828 · DOI · Paper page
- 10.1038/nrc3258 · DOI · Paper page
- 10.1038/nrc1252 · DOI · Paper page
- 10.1016/S0140-6736(14)61729-3 · DOI
- 10.1038/nature.2015.16990 · DOI
- 10.1158/1078-0432.CCR-09-2891 · DOI · Paper page
- 10.1016/j.cytogfr.2013.01.005 · DOI · Paper page
- 10.1038/nrc3380 · DOI · Paper page
- 10.1111/j.1600-065X.2007.00573.x · DOI · Paper page
- 10.4049/jimmunol.1401417 · DOI · Paper page
- 10.1038/sj.cdd.4402269 · DOI · Paper page
- 10.1038/nri2215 · DOI · Paper page
- 10.1021/acs.chemrev.5b00109 · DOI · Paper page
- 10.1016/j.nantod.2017.10.008 · DOI
- 10.1021/ar200017e · DOI · Paper page
- 10.1002/anie.200903112 · DOI · Paper page
- 10.1002/ange.200903112 · DOI
- 10.1073/pnas.0508677102 · DOI · Paper page
- 10.1038/nchem.2236 · DOI · Paper page
- 10.1038/nnano.2014.130 · DOI · Paper page
- 10.1021/cr300068p · DOI · Paper page
- 10.1039/C1CS15166E · DOI · Paper page
- Hong E., 2018, Adv. Drug Deliv. Rev.
- 10.1021/nn500299p · DOI · Paper page
- 10.1126/science.1077229 · DOI · Paper page
- 10.1021/nl015681q · DOI · Paper page
- 10.1016/j.yexcr.2016.10.006 · DOI
- 10.4049/jimmunol.182.3.1449 · DOI · Paper page
- 10.1186/s40425-017-0284-8 · DOI · Paper page
- 10.1038/nri3843 · DOI · Paper page
- 10.1016/j.biomaterials.2011.11.063 · DOI
- 10.1016/j.addr.2017.06.008 · DOI
- 10.1016/j.nano.2014.01.011 · DOI · Paper page
- 10.1002/biot.201100045 · DOI · Paper page
- 10.2217/nnm.14.106 · DOI
- Yanase M., 1998, Cancer Sci., 89, 775
- 10.1002/pros.20253 · DOI
- 10.4236/jbnb.2012.32020 · DOI
- Jimbow K., 2013, J. Skin Cancer, 2013
- 10.2217/nnm.12.142 · DOI
- 10.1111/j.1349-7006.2003.tb01438.x · DOI · Paper page
- 10.1038/sj.cgt.7700648 · doi:10.1038/sj.cgt.7700648
- 10.1007/s00262-003-0416-5 · doi:10.1007/s00262-003-0416-5
- 10.7150/thno.14988 · DOI · Paper page
- 10.1016/j.biomaterials.2017.09.014 · DOI · Paper page
- 10.1021/nn5002112 · DOI · Paper page
- 10.1016/j.biomaterials.2014.08.036 · doi:10.1016/j.biomaterials.2014.08.036
- 10.1039/C7NR01460K · doi:10.1039/c7nr01460k
- 10.1016/j.biomaterials.2011.12.029 · DOI · Paper page
- 10.7150/thno.19826 · DOI
- 10.1016/j.msec.2015.08.006 · DOI
- 10.1002/adma.201402996 · DOI · Paper page
- 10.1016/j.nano.2016.10.015 · DOI
- 10.1038/ncomms13193 · DOI · Paper page
- 10.1038/s41598-017-09116-1 · DOI
- 10.1016/S1470-2045(07)70318-2 · DOI
- 10.1038/nrc1894 · DOI · Paper page
- 10.1021/cr900300p · DOI · Paper page
- 10.1016/j.addr.2008.08.003 · DOI · Paper page
- 10.1021/cr5004198 · DOI · Paper page
- 10.1021/acsnano.7b04736 · DOI
- 10.1039/C2IB20125A · doi:10.1039/c2ib20125a
- 10.1021/jacs.6b09538 · DOI · Paper page
- 10.1021/jacs.8b01072 · DOI · Paper page
- 10.1021/acs.nanolett.6b01994 · DOI · Paper page
- 10.1021/jacs.6b06663 · DOI · Paper page
- 10.1021/acsnano.7b09112 · DOI · Paper page
- 10.1021/acsnano.7b00715 · DOI · Paper page
- 10.1016/j.radonc.2011.05.051 · DOI
- 10.1158/0008-5472.CAN-12-0851 · DOI
- 10.3389/fonc.2012.00088 · DOI · Paper page
- 10.3389/fonc.2012.00075 · DOI
- 10.4049/jimmunol.174.1.90 · DOI
- 10.1016/j.ijrobp.2011.09.049 · DOI · Paper page
- 10.3389/fonc.2012.00101 · DOI
- 10.1016/j.molmed.2015.05.007 · DOI
- 10.1172/JCI67313 · DOI · Paper page
- 10.3389/fonc.2012.00089 · DOI · Paper page
- 10.3389/fonc.2012.00090 · DOI
- 10.3389/fonc.2012.00153 · DOI · Paper page
- 10.1038/nnano.2017.113 · DOI · Paper page
- 10.3389/fonc.2012.00136 · DOI
- 10.1007/s11060-016-2289-4 · doi:10.1007/s11060-016-2289-4
- Jestin E., 2007, Q. J. Nucl. Med. Mol. Imaging, 51, 51
- 10.1371/journal.pone.0016926 · doi:10.1371/journal.pone.0016926
- 10.1016/j.biomaterials.2011.05.067 · DOI
- 10.1038/32183 · DOI · Paper page
- 10.1038/cdd.2013.84 · DOI · Paper page
- 10.1016/j.biomaterials.2016.06.032 · DOI · Paper page
- 10.1021/acs.nanolett.6b01432 · DOI
- 10.1038/mt.2012.229 · DOI
- 10.1021/mp800177f · DOI
- 10.1016/j.jconrel.2009.09.014 · doi:10.1016/j.jconrel.2009.09.014
- 10.1016/j.biomaterials.2010.09.013 · DOI · Paper page
- 10.1016/j.actbio.2017.11.010 · DOI
- 10.1126/sciadv.aao1736 · DOI · Paper page
- 10.1021/mp100153r · doi:10.1021/mp100153r
- 10.1007/s11095-012-0756-y · DOI
- 10.1016/j.ijpharm.2013.01.045 · DOI
- 10.1016/j.biomaterials.2014.05.076 · DOI
- Heo M. B., 2015, Int. J. Nanomed., 10, 5981
- 10.1016/j.biomaterials.2014.04.073 · DOI
- 10.1038/ncomms12499 · DOI · Paper page
- 10.1038/s41467-017-01050-0 · DOI · Paper page
Cited by
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
Ji, B., Wei, M., & Yang, B. (2022) · Theranostics · doi:10.7150/thno.67300 · Cited by 544
Ding, B., Zheng, P., Jiang, F., Zhao, Y., Wang, M., Chang, M., Ma, P., & Lin, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005111 · Cited by 341
Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., Jia, R., et al. (2020) · Advanced Materials · doi:10.1002/adma.202002085 · Cited by 309
Gathering brings strength: How organic aggregates boost disease phototheranostics
Qi, J., Ou, H., Liu, Q., & Ding, D. (2021) · Aggregate · doi:10.1002/agt2.25 · Cited by 284
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Metadata
- Authors
- Duan, X., Chan, C., & Lin, W.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2018-11-15
- Volume
- 58
- Issue
- 3
- Pages
- 670-680
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2883164386
- Cited by
- 1,033
- References
- 19
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Cancer Institute (U01-CA198989, 1R01CA216436)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. https://app.cochat.ai/papers/10.1002/anie.201804882
- The paper
- Duan, X., Chan, C., & Lin, W. (2019). Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.201804882
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.